50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Myeloproliferative Disorders (Philadelphia Chromosome-Negative)

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Myeloproliferative Disorders (Philadelphia Chromosome-Negative)

Saturday, December 6, 2008: 4:00 PM-5:30 PM

Gateway Ballroom - South (Moscone Center)

Sunday, December 7, 2008: 9:30 AM-11:00 AM

Gateway Ballroom - South (Moscone Center)

The JAK2V617F Mutation in PV and Other MPDs: One Mutation, Three Diseases

Chloé James, MD, PhD

Université Bordeaux 2, INSERM U876, Bordeaux, France

New Advances in the Pathogenesis and Therapy of Essential Thrombocythemia

Ross L. Levine, MD

Memorial Sloan-Kettering Cancer Center, New York, NY

From Palliation to Epigenetic Therapy in Myelofibrosis

Alessandro Rambaldi, MD

Ospedali Riuniti di Bergamo, Bergamo, Italy

See more of: Education Program

<< Previous Session | Next Session >>